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Abstract: Aging is a universal process to all life forms. The most current and widely accepted 
defi nition for aging in humans is that there is a progressive loss of function and energy produc-
tion that is accompanied by decreasing fertility and increasing mortality with advancing age. 
The most obvious and commonly recognised consequence of aging and energy decline is a 
decrease in skeletal muscle function which affects every aspect of human life from the ability 
to play games, walk and run to chew, swallow and digest food. There is hence a recognised 
overall decline of an individuals’ fi tness for the environment that they occupy. In Westernised 
countries this decline is gradual and the signs become mostly noticeable after the 5th decade 
of life and henceforth, where the individual slowly progresses to death over the next three to 
four decades. Given that the aging process is slow and gradual, it presents with opportunities 
and options that may ameliorate and improve the overall functional capacity of the organism. 
Small changes in function may be more amenable and likely to further slow down and possibly 
reverse some of the deleterious effects of aging, rather, than when the incremental changes are 
large. This overall effect may then translate into a signifi cant compression of the deleterious 
aspects of human aging with a resultant increase in human life expectancy.
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Introduction
Understanding the difference between life expectancy and lifespan is the framework 
upon which any selective review of anti-aging interventions must originate from. 
Human life expectancy is determined from mortality data tables. Life expectancy 
is a statistical projection of the length a human being is expected to live based upon 
probabilities and assumptions of genetic predispositions, living conditions, medical 
discoveries and advances, natural disasters and other environmental factors. Morbidity 
statistics track presumed causes of death over time, producing trend data that can be 
factored into life expectancy tables (Mathers and Loncar 2005). Lifespan, however, is 
defi ned as the characteristic observed age of death for its very oldest individuals.
Throughout most of recorded human history, it has been recognized that poor 
socioeconomic and nutritional status, have been strongly associated with decreased 
life expectancy, a trend that is also very much evident today (US Gov. Report, 2005). 
Current data estimates, show that on average human life expectancy in western countries 
is approximately 82 years for women and 80 years for men (US Gov. Report, 2005).
In this brief selective review we present scientifi c evidence as to what anti aging prac-
tices may better serve to increase mean life expectancy and hence the human lifespan.
Lifestyle
Willet (2002) recently emphasized that genetic and environmental factors, including 
diet and lifestyle, both contribute to cardiovascular diseases, cancers, and other major 
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causes of mortality and that numerous lines of evidence 
indicate that environmental factors are the most important 
in determining disease prevention. Hence, environmental 
factors may certainly have the strongest infl uence on life 
expectancy and hence lifespan (Figure 1) (Willett 2002; 
Vitetta et al 2005). Intertwined with nutritional practices and 
lifestyle is life stressor modifi cation (Vitetta et al 2005).
Evidence continues to accumulate that strongly suggests 
that the state of a human being’s mind – which associates 
psychosocial factors with emotional states such as depression 
and with behavioural dispositions that include hostility and 
psychosocial lifestyle stresses – can directly and signifi cantly 
infl uence human physiologic function and, in turn, health 
outcomes.
Stressors and negative stress-related reactions have 
been documented and recognized to have multiple ill health 
related sequalae and exposure to chronic social stress has 
been associated with many systemic and mental disorders. 
These have signifi cant deleterious outcomes that signifi cantly 
decrease life expectancy (Ader 2003; Vitetta et al 2005).
Different research groups support the notion that health 
consequences are more likely to occur when unpredictable 
stressors of a social nature chronically induce physiological 
and behavioral adjustments that may create wear and tear on 
underlying physiological functions. When stressors challenge 
an organism’s integrity, a set of physiological reactions is 
elicited to counteract the possible threat and adjust the physi-
ological setting of the organism to the new situation. This has 
become known as the stress response (Ader 2003). Stresors 
and lifestyle choices can be a signifi cant trigger for disease 
through immunomodulation of the immune system enhancing 
disease susceptibility, which can then affect life expectancy 
(Ader 2003). Immune function modulation infl uenced and 
expressed by stressful life experiences has a signifi cant 
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Figure 1 Preventable chronic diseases. Adapted and modifi ed from Willett 2002.
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correlate with Willett’s (2002) environmental trigger view 
of disease initiation.
Nutrition
Triggers for adverse and inappropriate nutritional practices in 
childhood have been shown to have psychosocial correlates in 
adult life with an increase in risk for disease (Jackson 2005). 
Obesity in humans, infl uenced by poor dietary choices and 
inactivity, are signifi cantly associated with an increased risk 
of chronic diseases such as diabetes, high blood pressure, 
high cholesterol, cardiovascular diseases, asthma, arthritis, 
some cancers and overall poor health status, that can signifi -
cantly decrease an individual’s life expectancy.
CR is linked to nutritional choices. CR with nutritionally 
poor foods (eg, consuming half the quantity of a fast food) 
is still an unbalanced nutritional choice albeit in smaller 
portions and still provides no health advantage.
Recently it was reported and further confi rmed, that a 
greater adherence to a traditional Mediterranean diet was 
associated with a signifi cant reduction in total all cause mor-
tality (Trichopoulou et al 2003). Meyer and colleagues (2006) 
have demonstrated that associating a CR diet with adherence 
to a Mediterranean type diet that consisted of whole grains, 
beans, fi sh, fruit, olive oil, and many different kinds of veg-
etables was benefi cial for heart health. Hence when optimal 
nutritional choices are coupled to CR, an increase in life 
expectancy is made possible. Such nutritional practices can 
serve to further expand the human life span.
Caloric restriction (CR)
Optimizing nutrition relates food intake to the benefi ts of 
prudent CR. That is, CR refers to a dietary regimen low 
in calories without under nutrition that leads to increased 
disease risk due to nutritional defi cits. Following the pio-
neering work of McCay and Maynard (1935) over 70 years 
ago, CR was then fi rst noted to signifi cantly extend the life 
span of rodents. Since that time, the increase in longevity 
has been demonstrated to result from the limitation of total 
calories derived from carbohydrates, fats, or proteins to a 
level 25%–60% below that of control animals that were 
fed ad libitum (Sohal and Weindruch 1996; Weindruch 
and Sohal 1997; Weindruch et al 2001). The extension in 
lifespan can approach 50% in rodents (Figure 2) (McCay 
et al 1935; Holloszt 1997). Moreover, CR has been shown 
to extend the lifespan in a broad range of organisms that 
include, yeast, rotifers, spiders, worms, fi sh, mice, and rats 
(Weindruch et al 2001). Emerging data show that its effect 
may also apply to non human primates (Lane et al 2001). Also 
CR has been reported to delay a wide spectrum of diseases 
in different experimental animals such as kidney disease 
(Lane et al 2001), a variety of neoplasias (Fernandes et al 
1976; Fernandes and Good 1984; Kubo et al 1984), autoim-
mune disease (Sarkar et al 1982; Engelman et al 1990) and 
diabetes (Shields et al 1991), and it reduces age associated 
neuronal loss in most mouse models of neurodegenerative 
disorders such as Parkinson’s Disease (Duan and Mattson 
1999) and Alzheimer’s Disease (Zhu et al 1999). The CR 
regimen also prevents age-associated declines in psychomo-
tor and spatial memory tasks (Ingram et al 1997) and loss of 
dendritic spines necessary for learning (Moroi-Fetters et al 
1989) and improves the brain’s plasticity and ability for self 
repair (Mattson 2000).
Numerous biomarkers of CR have been identifi ed in 
rodents, such as temperature, and DHEAS, insulin and 
glucose levels (Roth et al 2002). Roth and colleagues (2002) 
have recently observed that body temperature and insulin 
and DHEAS levels were also altered in primates that had 
been subjected to CR, hence validating the usefulness of 
these biomarkers in longer-lived species. More importantly, 
they have also shown that these parameters were altered in 
longer-lived men. Together these fi ndings support the role 
these factors have as biomarkers of longevity in humans.
Recently, a trial on the effect of a 6 month CR diet 
on metabolic biomarkers such as energy expenditure, and 
oxidative stress in humans was completed (Heilbronn et al 
2006). The report showed that prolonged CR signifi cantly 
reduced two biomarkers of longevity, namely, fasting insulin 
level and body temperature. This is the fi rst human study to 
show that CR, in addition to signifi cant reductions in well 
known biomarkers of aging, also caused a metabolic adapta-
tion in CR individuals and a reduction in DNA fragmentation 
that refl ected less DNA damage (Heilbronn et al 2006).
Important genetic links and regulators of organism life 
span have been uncovered in the form of sirtuins (Sauve et al 
2006) Sirtuins are a family of NAD+  – dependent protein 
deacetylases widely distributed in all phyla of life. In multicel-
lular organisms, sirtuins deacetylate histones and transcription 
factors that regulate stress, metabolism, and survival pathways. 
Sir2 is the founding member of a large and diverse family 
of  these protein-modifying sirtuin enzymes, which regulate 
key pathways throughout biology, in eubacteria, archaea, 
eukaryotes, and even viruses (Sauve et al 2006).
The link between CR and Sir2 and aging has been reviewed 
elsewhere (cf. for reviews: refer Sinclair and Guarente 1997; 
Guarente and Picard 2005; Suave et al 2006). We further 
point out that there is an extensive body of evidence that 
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suggests that sirtuins are involved in promoting longevity, 
particularly longevity associated with CR regimens, in several 
organisms. The sirtuin – CR relationship remains complex 
however. Recently Suave and colleagues (Sauve et al 2006) 
hypothesized that mammalian SIRT1 may mediate signifi cant 
changes in tissues and endocrine systems through the sensing 
of low CR diets and triggering physiological changes that 
benefi t mammals with health and hence longevity.
Plant factors such as resveratrol have been shown to increase 
longevity in several organisms by regulating Sir2/SIRT1 (cf. for 
review: Baur and Sinclair 2006). In mammals, there is growing 
evidence that resveratrol can prevent or delay the onset of can-
cer, heart disease, ischaemic and chemically induced injuries, 
diabetes, pathological infl ammation and viral infection. These 
effects are observed despite extremely low bioavailability and 
rapid clearance of resveratrol from the circulation (Baur and 
Sinclair 2006). Resveratrol has been suggested to be associ-
ated with the prevention of age-related diseases such as cancer 
because of its regulation of transcription factors that control 
tumuor cell survival (Guarente and Kenyon 2000; Howitz et al 
2003; Nemoto et al 2005; Storz 2005).
Mitochondria and free radicals
That mitochondria have a pivotal role in the effective provi-
sion of energy to eukaryotic cells is an undisputed scientifi c 
fact. Cellular mechanisms regulating energy utilization must 
function properly to sustain life. Adenosine 5′–triphosphate 
(ATP) is the ubiquitous energy storage molecule produced 
in several cellular processes. Aerobic energy metabolism 
requires a cellular investment, namely, molecular oxygen. 
Humans rely on mitochondria to synthesize and export 
ATP. The process is initiated by the transfer of electrons 
derived from food sources along a series of mitochondrial 
respiratory–chain carriers until they are consumed with the 
production of water from the utilization of oxygen. A single 
eukaryotic cell may contain between several hundred to 
thousands of these energy organelles. With increased aging, 
there is a decrease in mitochondrial energy output (Singh 
2006). Hence in aerobic animals, mitochondrial health for 
effective energy provision is central to life.
The free radical theory of aging, as formulated by 
Denham Harman (1956), is supported by observations that 
the life span of most organisms is roughly proportional to 
their metabolic rate and thus due to the rate at which the 
organism generates mitochondria derived reactive oxygen 
species (ROS). This view however, is over simplistic and 
may require modifi cation within the confi nes of aging. 
Cellular generated ROS contributing to the overall produc-
tion of ROS are apparently traced back to the mitochondria 
(Lenaz et al 2002). ROS have been viewed as mostly 
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Figure 2 Effect of CR and Exercise on Survival in rats.  Adapted and modifi ed from Holloszy 1995. 
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deleterious to health and hence aging. Reports that show 
that in a wide spectrum of animal species, dietary antioxi-
dants or caloric restriction, as well as chemical antioxidants 
or increased expression of antioxidant proteins, can lower 
mitochondria ROS production, which translates into an 
extension of the life span of these species which have served 
to support the free radical theory of aging (Orr and Sohal 
1994; Sohal and Weindruck 1996; Parkes et al 1998; Sun 
and Tower 1999; Taub et al 1999; Schon 2000; Finkel and 
Holbrook 2000; Xu and Finkel 2002) However, it is known 
that ROS are generated in multiple cellular compartments 
and by multiple enzyme systems within the cell and have 
cellular signaling functions that are critical for the normal 
physiological function of the cell (Rhee et al 2003; Linnane 
et al 2007a, 2007b, 2007c).
Important contributions to the production of ROS within 
cells, include proteins within the plasma membrane, such 
as the growing family of NADPH oxidases; lipid metabo-
lism within the peroxisomes; protein synthesis within the 
endoplasmic reticulum; as well as the activity of various 
cytosolic enzymes such as the cyclo-oxygenases (Linnane 
and Eastwood 2004; Moldovan and Moldovan 2004; 
Balaban et al 2005). The generation of mitochondrial ROS 
is a consequence of oxidative phosphorylation, a process 
that uses the controlled and regulated oxidation of NADH 
or FADH to generate a potential energy for protons across 
the mitochondrial inner membrane (ROS produced by mito-
chondria have been demonstrated to have important and 
specifi c roles in cellular signalling (Linnane and Eastwood 
2004). The notion that the mitochondria are the sole most 
abundant site of ROS formation is currently an area of much 
discussion and debate (Rhee et al 2003; Balaban et al 2005; 
Linnane et al 2007b).
The disruption of mitochondrial functions has been 
implicated in more than 40 known diseases, including ath-
erosclerosis, ischemic heart disease, cancer, diabetes, and 
neurodegenerative diseases such as Alzheimer’s disease, 
Parkinson’s disease, Huntington’s disease, and amyotrophic 
lateral sclerosis (cf. for reviews: McKenie 2004; Wallace 
2005). Together these data indicate that mitochondrial 
health is an important factor for health and aging. Current 
and future research would aim to further improve and pre-
serve mitochondrial function. Although further research is 
warranted, recent reports show that supplementation with 
coenzyme Q
10
 shows promise in maintaining the health of 
mitochondria (Kagan et al 1999; Crestanello et al 2002; 
McKenzie et al 2004; Somayagulu et al 2005; Linnane 
et al 2007b).
Further, mimetics of specifi c cellular antioxidants such 
as the SOD/catalase mimetic EUK-134 can be used to assist 
in reducing oxygen radicals and are already in clinical trials 
(Melov et al 2000).
Hormones
In humans there is a progressive decrease in hormone 
synthesis as well as a loss of hormone receptors with age. 
The elderly have demonstrated signifi cantly lower levels 
of production of most hormones compared to young adults 
(Hertogue 2005). There is a voluminous body of scientifi c 
literature concerned with hormonal defi cits with aging. 
That is, levels of growth hormone (GH) and insulin like 
growth factor-1 (IGF-1), melatonin (nocturnal), TSH, 
thyroid hormones (T3), calcitonin, DHEA (sulphated 
form in and its urinary 17-keto-metabolites), aldoste-
rone, estrogens, testosterone in men and women have 
been demonstrated to progressively decrease with age 
in adults (for extensive review and individual references 
refer Hertogue 2005).
Hormonal defi cits are not merely limited to menopause, 
andropause (male menopause), somatopause (adult growth 
hormone defi ciency), and other sex hormone related diseases, 
they are now implicated in conditions such as obesity (Cranny 
et al 2006; Pasquali and Gambineri 2006), osteoporosis 
(Bennett 2005), fi bromyalgia (Cleare 2004) chronic fatigue 
syndrome (Cleare 2004) cancer (Simonenko et al 2006) 
attention defi cit problems (Cheng 2005) and possibly others 
as yet that remain to be elucidated.
Conventional medicine treatments have only severed to 
address hormone depletion, ignoring the mild and moderate 
defi ciencies; whereas the anti-aging medicine model focuses 
on mild, moderate, and severe deficiencies. Symptoms 
and severity of symptoms will be proportional to the level 
of defi ciency for each hormone (Anton et al 2005). Only 
recently has the science of endocrinology started focusing 
on advanced testing methods, taking into account reference 
ranges based on age as well as gender, free or bioavailable 
hormone levels versus bound hormone levels, and ratios 
between major antagonistic hormones to titrate patients 
and achieve an optimum balance. Titration and optimum 
balance have been used with thyroid and insulin hormones, 
and has not been universally applied to all other hormones, 
till recent times. Ongoing research in the fi eld of longevity 
should include the use of nutrient and hormonal precursors to 
augment the body’s ability to make more of its own hormonal 
compounds thus limiting structural and DNA damage in the 
latter decades of life.
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Concluding remarks
The purest use of the term “biological aging” confi nes it 
exclusively to molecular changes. Hayfl ick (2003) defi nes 
aging in biological systems as a stochastic process that occurs 
systemically after reproductive maturity in animals that reach 
a fi xed size in adulthood and that it is then caused by the esca-
lating loss of molecular fi delity that ultimately exceeds repair 
capacity. This then increases the vulnerability to pathology 
or age-associated diseases. Further, that there is a fi nitude 
associated with aging that eventually leads to death (Hayfl ick 
2003). Grimley Evans (2000) defi ned senescent changes as de 
novo structural and functional alterations that are not part of 
the developmental program. In this selective and brief review 
we have summarized the scientifi c evidence that may prevent 
disease and maintain the molecular integrity of the organism, 
thus expanding the mean life expectancy whilst operating 
within the framework of normal physiological function 
and repair. We fi nd that whilst aging is not irreversible and 
inevitable, certain key factors may add signifi cant benefi ts 
to human mean life expectancy.
There is a vast array of scientifi c literature that concludes 
that lifestyle modifi cation factors that optimize nutrition, 
physical activity and mental health have signifi cant correlates 
with reducing the risks of disease in later life that is translates 
into an increased mean life expectancy. Further, although the 
correction of all hormonal defi cits by an adequate multiple 
hormone replacement therapy, is not currently possible, 
hormone therapy does constitute a viable solution to prevent 
and treat most hormonal defi cits due to pathological aging. 
Hertogue (2005) recently reported that even though we are 
not presently able to abrogate senescence by hormone treat-
ments because of the unavailability as medications of all hor-
mones that decline with age, the future appears promising.
As a fi nal note; with the onset of the 21st century, it is 
apparent that we stand on the horizon of a revolution in anti 
aging therapies and technologies. A promising therapeutic 
modality, the concept of stem cell treatments, will within the 
next decade, allow a markedly expanded quality of health and 
possibly also further increase the mean human life expec-
tancy. Recent advances by major corporations, both private 
and public, have documented that we are already capable of 
taking stem cells from an individual and selectively copy-
ing these cells along with their DNA components. Thus 
making possible the restoration and rejuvenation properties 
that human bodies lose as they age. The prospects for use 
of human embryonic stem cells derivatives in regenera-
tive medicine hence are signifi cant (Trouson 2006). If, the 
potential contributions to human regenerative medicine can 
be realized, signifi cant alterations and enhancement of mean 
life expectancy in humans will be possible.
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